Blackstone Inc’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.5M | Buy |
1,320,592
+558,285
| +73% | +$11.2M | 0.11% | 56 |
|
|
2025
Q1 | $15M | Buy |
762,307
+388,984
| +104% | +$7.66M | 0.06% | 64 |
|
|
2024
Q4 | $8.4M | Hold |
373,323
| – | – | 0.04% | 77 |
|
|
2024
Q3 | $9.53M | Buy |
373,323
+52,143
| +16% | +$1.33M | 0.04% | 75 |
|
|
2024
Q2 | $7.51M | Buy |
321,180
+295,989
| +1,175% | +$6.92M | 0.03% | 80 |
|
|
2024
Q1 | $443K | Buy |
+25,191
| New | +$443K | ﹤0.01% | 151 |
|